17th Annual IDMA – APA Pharmaceutical Analysts’ Convention held
The theme for this year’s convention was, 'Challenges in Global Quality Management'
Author
Study confirms positive safety profile and effectiveness of Pradaxa in atrial fibrillation patients
The US FDA Medicare study of 134,000 patients demonstrates benefits such as a significantly reduced risk of ischaemic stroke, a…
Phase III efficacy clinical study results of Sanofi’s Dengue vaccine candidate published
Study successfully met primary objective and confirms high efficacy against severe dengue and hospitalisation
Multisorb Technologies appoints Peter Lirusso to Healthcare Packaging Group for Canada
Lirusso brings vast experience in films, foils, and ridged plastics and blister packs within the pharmaceutical industry. And…
Biocon expands its strategic partnership with CytoSorbents
Biocon will now have the exclusive, region-wide rights to distribute CytoSorb for all critical care applications in the ICU as…
Indian Patent office issues new guidelines for pharmaceutical patent applications
Generic disclosure in the prior art may not necessarily take away the novelty of a specific disclosure
World Ayurveda Congress aims to boost traditional Indian healing systems
200 practitioners to attend Nov 6-7 healers meet
Lupin gets US FDA approval for generic Celebrex capsules
Lupin's Celecoxib capsules are the AB-rated generic equivalents of GD Searle LLC 's Celebrex capsules
Celanese discusses innovative uses for EVA polymers at AAPS, San Diego
EVA applications expanded into oral dosage
Suven begins phase I trial of NCE SUVN-G3031 in US
SUVN-G3031 is for cognition in alzheimer’s disease under US-IND 123179